(NasdaqGM:SAMG), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) is pleased to announce the promotion of Jeffrey C. Allen, CFA, and Alexander I. Waldorf, CFA, to Co-Portfolio Managers for the U.S. Value Equity Team. They will work alongside Roger Vogel, the Lead Portfolio Manager of the team and […]
(NASDAQ:WWD), FORT COLLINS, Colo., July 28, 2025 (GLOBE NEWSWIRE) — Today, Woodward, Inc. (NASDAQ:WWD) reported financial results for its third quarter of fiscal year 2025. All amounts are presented on an as reported (U.S. GAAP) basis unless otherwise indicated. All per share amounts are presented on a fully diluted basis. All comparisons are made to
(NasdaqGM:FULC), CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, will host a conference call and webcast on Tuesday, July 29, 2025 beginning at 8:00 a.m. ET to present topline
(NASDAQ:ASTE), CHATTANOOGA, Tenn., July 28, 2025 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on or about August 29, 2025, to shareholders of record as of the close of business on August 11, 2025. About
Silvercrest Asset Management Group Appoints Jeffrey C. Allen and Alexander I. Waldorf as Co-Portfolio Managers for the U.S. Value Equity Team GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) is pleased to announce the promotion of Jeffrey C. Allen, CFA, and Alexander I. Waldorf,
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease GlobeNewswire July 28, 2025 CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of
Astec Announces Quarterly Dividend GlobeNewswire July 28, 2025 CHATTANOOGA, Tenn., July 28, 2025 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on or about August 29, 2025, to shareholders of record as of the close
Woodward Reports Third Quarter Fiscal Year 2025 Results Raises 2025 Sales and Earnings Guidance on Strong Year-to-Date Performance and Outlook GlobeNewswire July 28, 2025 FORT COLLINS, Colo., July 28, 2025 (GLOBE NEWSWIRE) — Today, Woodward, Inc. (NASDAQ:WWD) reported financial results for its third quarter of fiscal year 2025. All amounts are presented on an as
Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or “the Company”) (NYSE: FI) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities
Attorney Advertising– Bronstein,Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws